Robert Hubbard, PhD

Robert Hubbard, PhD, is an accomplished medicinal chemist with expertise in multiple therapeutic modalities, such as small-molecules, antibody-drug conjugates, and nanoparticles. Prior to his role at Amplify, he was the vice president, head of drug discovery at Coho Therapeutics. Previously, he was a director of medicinal chemistry at Vividion, leading a team to discover novel bifunctional degraders. In his career, he worked in several therapeutic areas, including oncology, immunology, and, most recently, in neuroscience. Robert received his BS in chemistry at Indiana University, Bloomington, Indiana. Subsequently, he received his MS and PhD in chemistry at the University of Rochester.